Kimberly A. Kraynyak, Ph.D.

Affiliations: 
2009 University of Pennsylvania, Philadelphia, PA, United States 
Area:
DNA vaccine, HIV
Google:
"Kimberly Kraynyak"
Mean distance: 23748
 

Parents

Sign in to add mentor
David B. Weiner grad student 2009 Penn
 (Modulation of the immune response at systemic and mucosal sites by DNA vaccine adjuvants in HIV and influenza models.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shore ND, Morrow MP, McMullan T, et al. (2020) CD8 T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens. Molecular Therapy : the Journal of the American Society of Gene Therapy
Aggarwal C, Cohen RB, Morrow MP, et al. (2020) Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis. Vaccines. 8
Tebas P, Kraynyak KA, Patel A, et al. (2019) Intradermal SynCon® Ebola GP DNA Vaccine is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. The Journal of Infectious Diseases
Patel A, Reuschel EL, Kraynyak KA, et al. (2018) Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines. The Journal of Infectious Diseases
Schultheis K, Smith TRF, Kiosses WB, et al. (2018) Delineating the cell death mechanisms associated with skin electroporation. Human Gene Therapy Methods
Morrow MP, Kraynyak K, Sylvester AJ, et al. (2017) Clinical and Immunological Biomarkers for Histologic Regression of High Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Muthumani K, Marnin L, Kudchodkar SB, et al. (2017) Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody. Cancer Immunology, Immunotherapy : Cii
Smith TRF, Schultheis K, Morrow MP, et al. (2017) Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus. Vaccine
Walters JN, Ferraro B, Duperret EK, et al. (2017) A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity. Molecular Therapy : the Journal of the American Society of Gene Therapy
Muthumani K, Griffin BD, Agarwal S, et al. (2016) In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. Npj Vaccines. 1: 16021
See more...